Obtain Sufficient Support From the Vaccine Solution Center of Creative Biolabs

 Breaking News
  • No posts were found

Obtain Sufficient Support From the Vaccine Solution Center of Creative Biolabs

June 16
19:44 2020
Creative Biolabs is outputting solutions and products to support vaccine development throughout the world, even under the current COVID-19 pandemic, with the aim of accelerating the pace of vaccine development projects from pharmaceuticals and research institutes.

New York, USA – June 16, 2020 – The COVID-19 is rampaging all around the world, with over 7.69M cases confirmed globally and 428K patients died by now, which is a huge threat that affects the life and safety of humans. According to the document-Draft Landscape of COVID-19 Candidate Vaccines, there are eight vaccines entering the clinical trial stage, along with over 100 candidates under development. The urgent requests of effective and safe vaccines against the novel coronavirus have brought great challenges to pharmaceutical companies and research organizations, which therefore urge the entire vaccine industry to expedite research progress by taking advantage of high-end technologies, meanwhile searching assistance from the CRO companies. Creative Biolabs is one of those who are fully competent to deal with such emergencies, through sophisticated vaccine technologies and the necessary raw materials for vaccine research.

How can the vaccine solutions help?

Creative Biolabs can deal with the entire pipeline of vaccine development, starting from the design stage to help develop a broad range of vaccine types, such as live attenuated and killed vaccine, subunit vaccine, and RNA vaccine that is currently taken as the most promising type to defeat COVID-19. Except for regular procedures involved in the vaccine development stage, Creative Biolabs can give a hand in process development & GMP manufacturing after in vivo and in vitro tests that ensure safety and potency of the developed vaccines.

What substances get involved during the vaccine development process?

The process of vaccine development calls for various substances, ranging from small molecules to detection kits and culture media, which are all available at Creative Biolabs and supplied at competitive prices. By summarizing from different customer requests and orders these years, Creative Biolabs expands the product portfolio. There are different categories of vaccine antigens to choose from that meet with assorted research purposes, like viral antigens, bacterial antigens, fungal antigens, etc., covering hundreds of the antigens of microorganisms. The available adjuvants (Aluminium Adjuvants, Oil Adjuvants, Saponin Adjuvants, Lipopolysaccharide, molecules known to activate pattern recognition receptors (PRRs), referred to as PRR agonists and so on. Immunologic Adjuvants) of high sensitivity and affinity can assist with elevating the immune response to antigens and induce long-term protection.

“Our services are tailored upon requests,” said the head scientist at Creative Biolabs. The idea is well known and popular in the industry, allowing customers to find their tailored solutions. With the aim of solving this global crisis, Creative Biolabs never halts offering technical support and resourceful raw materials to work jointly to race against time.

About Creative Biolabs

Creative Biolabs is a US-based service provider of technology and high-quality products that are involved in vaccine development, preclinical assessment and GMP manufacturing. The core technical team is made up of a group of doctoral-level scientists who share profound knowledge and rich practical experience in relevant fields. After years of operation, Creative Biolabs successfully established a series of solutions accordingly, providing global customers assistance at almost every stage of their vaccine projects.

Media Contact
Company Name: Creative Biolabs
Contact Person: Candy Swift
Email: Send Email
Phone: 1-631-619-7922
Country: United States
Website: https://www.creative-biolabs.com/vaccine

Related Articles